General Information of DTT (ID: TTBMAOZ)

DTT Name Regulatory protein unspecific (RGP) DTT Info
Gene Name RGP

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Teplizumab DMZ3P6C Type-1 diabetes 5A10 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Visilizumab DMXYM1H Graft-versus-host disease 4B24 Phase 3 [2]
NI-0401 DMEOLVP Autoimmune diabetes 5A10 Phase 1/2 [3]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
MEDI-500 DMT3B4G Bone marrow transplantation QB63.6 Terminated [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Acquisition of regulatory function by human CD8(+) T cells treated with anti-CD3 antibody requires TNF. Eur J Immunol. 2010 Oct;40(10):2891-901.
2 Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. Clin Immunol. 2008 Jun;127(3):322-9.
3 Clinical pipeline report, company report or official report of NovImmune.
4 T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action. Clin Transplant. 1996 Dec;10(6 Pt 2):607-13.